According to a Nov. 2025 KFF poll, about one in eight U.S. adults (12 percent) is currently taking a GLP-1 weight-loss medication such as Ozempic or Wegovy. These drugs work by suppressing appetite, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results